As mentioned above, the SUMO protease SENP1 was identified as a factor that promotes the removal of C-terminal SUMO moieties from human HDAC1 in a prostate cancer model, causing upregulation of the androgen receptor (Cheng et al., 2004). Here, SENP1 is linked to prostate carcinoma.